First Bank & Trust Penumbra Inc Transaction History

First Bank & Trust

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$116.09 - $227.33 $4,295 - $8,411	-37 Closed	0 $0
Q1 2022 Apr 29, 2022	SELL	$187.51 - $283.98 $28,689 - $43,448	-153 Reduced 80.53%	37 $8,000
Q4 2021 Feb 01, 2022	SELL	$238.08 - $288.0 $55,472 - $67,104	-233 Reduced 55.08%	190 $55,000
Q2 2021 Aug 10, 2021	SELL	$235.0 - $310.7 $39,010 - $51,576	-166 Reduced 28.18%	423 $116,000
Q1 2021 Apr 14, 2021	SELL	$175.6 - $291.43 $134,860 - $223,818	-768 Reduced 56.6%	589 $159,000
Q4 2020 Jan 27, 2021	BUY	$174.98 - $272.83 $4,724 - $7,366	27 Added 2.03%	1,357 $237,000
Q3 2020 Oct 26, 2020	BUY	$185.27 - $238.73 $17,971 - $23,156	97 Added 7.87%	1,330 $258,000
Q2 2020 Aug 05, 2020	BUY	$153.32 - $191.72 $51,055 - $63,842	333 Added 37.0%	1,233 $221,000
Q1 2020 Apr 14, 2020	BUY	$124.34 - $193.76 $111,906 - $174,384	900 New	900 $145,000

373

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.19B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of First Bank & Trust, based on Form 13F filings with the SEC.

Stay updated on First Bank & Trust with notifications on news.